Articles
Podcast Highlights Pfizer Foundation’s Mission to Improve Breast Cancer Outcomes
For over 75 years, the Pfizer Foundation, a charitable organization, has worked toward the mission of helping build healthier communities around the world. By investing in locally led organizations and applying a community-centered approach, the Foundation aims to address today’s complex global health challenges, respond to urgent health needs, and empower Pfizer colleagues to make a positive impact where they live, work, and beyond.Launched in 2025, The Pfizer Foundation’s Action & Impact....
Not Quite Out of the Woods: Risk for Lyme Disease Prevails in Suburban Environments
When many people think about places associated with tick exposure and risk for getting Lyme disease, they may picture a hike in the country or a camping trip in the woods. But encounters with infected ticks that can cause Lyme disease can happen doing routine activities around the yard, and common outdoor activities in your everyday life can put you at heightened risk for tick bites and, in turn, contracting Lyme disease.1Lyme disease is a bacterial infection transmitted to humans through a bite....
What is Non-Muscle Invasive Bladder Cancer?
According to recent research, bladder cancer is the 12th most common type of cancer worldwide.1 Of these cases, doctors stage (referring to the process of how far the cancer has progressed) more than 75 percent as non-muscle invasive bladder cancer (NMIBC).1 Unlike other forms of bladder cancer, NMIBC only develops in cells that line the inside of the bladder, also known as urothelial or transitional cells.2 The bladder is made up of several layers, and in most cases, bladder cancer begins in....
April Social Media Round-Up—Trailblazer Cancer Research Grants, World Health Day, and More
April has come to a close and we are barreling towards the summer. Before you head outside to enjoy spring, take a moment to catch up with Pfizer’s social channels, which have been on fire.In April, Pfizer colleagues were honored in the list of 2026 Healthcare Businesswomen’s Association (HBA) Luminaries and Rising Stars, we recognized vaccines’ impact during World Immunization Week, and Pfizer scientists highlighted our research efforts.CEO Albert Bourla recognized Pfizer scientists who were....
Making Progress Against Cancer - From Cancer Research to Prevention and Screening
Advances in cancer care often begin with incremental steps in the lab that, over time, have the power to drive transformative breakthroughs. That’s why scientists are working around the clock to develop potential treatments that could help patients live longer, healthier lives. At Pfizer, Sharsti Sandall is one of those scientists.An executive director in Pfizer’s oncology research division, Sandall leads the antibody drug conjugate (ADC) group, which is a targeted treatment that delivers cancer....
How Biomarker Testing Helped a Lung Cancer Patient Get the Treatment She Needed
Earlier this month, Science Will Win, Pfizer’s award-winning podcast, wrapped up another successful season. Launched in February, season 6 included five episodes, each one focused on a different aspect of the fight against cancer, wrapping with last week’s season finale about AI’s impact on cancer care.All season long, each podcast episode has been accompanied by a full-length video conversation between host Dr. Raven Baxter – a molecular biologist and science educator – and one of her guests....
Science Will Win season finale explores AI in cancer care with Pfizer Chief Oncology Officer Jeff Legos
In February, Pfizer launched the sixth season of Science Will Win, our flagship podcast which recently reached 3 million downloads.The season finale focuses on the future of technology and artificial intelligence (AI) —and what they could mean for cancer research and care. Cancer research is moving faster than ever, but that progress is not always reflected in the patient experience. AI may be starting to change that. The last episode of Science Will Win Season 6 follows the human journey, from....
How AI Is Already Reshaping Cancer Care
When treating cancer, few things are more precious than time. Jeanine Bortel, Vice President and Head of AI Portfolio Development at Pfizer, who has developed clinical trials at Pfizer for more than two decades, remembers when she first witnessed the transformative potential of artificial intelligence (AI) put into practice to help address the needs of patients enrolled in cancer clinical trials.For years, Bortel’s work had run up against an inherent challenge: Many cancer patients miss out on....
Ever Wonder How Medicines Get Their Names?
Naming a medicine is more than just a creative exercise. It’s a critical, complicated, and collaborative step in bringing innovative treatments to patients.Some medicine names may sound unfamiliar, but there’s a lot of intention behind every syllable. Long before a treatment reaches patients, its name goes through a careful, highly regulated process designed to help prevent confusion and support safe use in real world healthcare settings.From early lab identifiers to globally recognized generic....
Behind the Science Features
What are ADCs? Targeting cancer with special drug delivery units
For centuries, humanity has hoped for a world where people with cancer live better, longer lives – and today that vision is closer than ever. Learn how antibody drug conjugates (ADCs) are emerging as one of the most powerful tools in cancer treatment.
Ever Wonder How Drugs Get Their Names?
Naming medications is not a simple process. It's a collaborative, conscientious effort, and one that is both an art and a science. Take a peek behind the curtain to see how drugs are named.
Understanding Obesity as a Complex Disease
Some people think obesity is simply caused by unhealthy eating habits and not exercising enough. But, in fact, the scientific and medical community defines obesity as a complex, multifactoral chronic disease.
Podcasts
eBooks
Subscriptions
Sign up for communications from Pfizer
Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics.
Sign Up Now Details
Newsroom
The latest media resources from Pfizer
Working journalist? Visit the Pfizer Newsroom for our complete library of news, announcements and multimedia assets.
Read More Details